Q32 Bio Inc. Interest Income (Expense), Net
Q32 Bio Inc. (QTTB) reported Interest Income (Expense), Net of -$246.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNet · last filed 2026-08-05
- Q32 Bio Inc. interest income (expense), net for the quarter ending 2026-06-30 was -$246.00K.
- Q32 Bio Inc. interest income (expense), net for the quarter ending 2026-03-31 was -$192.00K.
- Q32 Bio Inc. interest income (expense), net for the quarter ending 2025-12-31 was $1.93M, a 61.37% decline year-over-year.
- Q32 Bio Inc. interest income (expense), net for the quarter ending 2025-09-30 was -$220.00K.
- Q32 Bio Inc. interest income (expense), net for fiscal 2025 was $1.05M, a 62.75% decline from fiscal 2024.
- Q32 Bio Inc. interest income (expense), net for fiscal 2024 was $2.83M, a 308.66% increase from fiscal 2023.
- Q32 Bio Inc. interest income (expense), net for fiscal 2023 was $693.00K.
| Period end | Interest Income (Expense), Net 3 month | Interest Income (Expense), Net 6 month | Interest Income (Expense), Net 9 month | Interest Income (Expense), Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$246.00K 10-Q · filed 2026-08-05 | -$438.00K 10-Q · filed 2026-08-05 | $1.49M derived: sum of 3 quarters · filed 2026-08-05 | $1.27M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$192.00K 10-Q · filed 2026-05-05 | $1.74M derived: sum of 2 quarters · filed 2026-05-05 | $1.52M derived: sum of 3 quarters · filed 2026-05-05 | $1.23M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $1.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $1.71M derived: sum of 2 quarters · filed 2026-03-10 | $1.43M derived: sum of 3 quarters · filed 2026-08-05 | $1.05M 10-K · filed 2026-03-10 |
| 2025-09-30 | -$220.00K 10-Q · filed 2025-11-13 | -$504.00K derived: sum of 2 quarters · filed 2026-08-05 | -$875.00K 10-Q · filed 2025-11-13 | $4.12M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$284.00K 10-Q · filed 2026-08-05 | -$655.00K 10-Q · filed 2026-08-05 | $4.34M derived: sum of 3 quarters · filed 2026-08-05 | $3.42M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$371.00K 10-Q · filed 2026-05-05 | $4.63M derived: sum of 2 quarters · filed 2026-05-05 | $3.71M derived: sum of 3 quarters · filed 2026-05-05 | $2.64M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $4.08M derived: sum of 2 quarters · filed 2026-03-10 | $3.01M derived: sum of 3 quarters · filed 2026-03-10 | $2.83M 10-K · filed 2026-03-10 |
| 2024-09-30 | -$917.00K 10-Q · filed 2025-11-13 | -$1.99M derived: sum of 2 quarters · filed 2025-11-13 | -$2.16M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | -$1.07M 10-Q · filed 2025-08-06 | -$1.25M 10-Q · filed 2025-08-06 | ||
| 2024-03-31 | -$180.00K 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | $693.00K 10-K · filed 2025-03-11 |